Fully-funded projects integrate innovative technologies to allow investigators to expand scope of current research and obtain pilot data for future funding

Supported by SPrINT in collaboration with the NIH BRAIN initiative

Purpose

This program will fund six projects, which will be conducted by SPrINT using innovative Neuroscience Technologies. Projects that are selected will be fully conducted by SPrINT staff. We encourage project proposals that are highly innovative and that integrate a combination of behavior, genetics, viral technologies, imaging, and/or brain organogenesis techniques. Guidelines and Selection Criteria are indicated below. 

Technologies for dissemination and Pilot Projects include but are not limited to:

  • In vivo models of neurodegenerative disease (e.g., Alzheimer’s disease)
  • Animal behavior (e.g., Morris Water Maze, Fear Conditioning, Intellicage…)
  • Drug efficacy studies
  • Behavioral phenotyping
  • Whole brain clearing and imaging
  • Proteomics and Transcriptomics
  • Array Tomography
  • Super-resolution volumetric imaging
  • STARmap (in tissue single cell transcriptomics)
  • Gene and viral vector technologies
  • Stereotaxic injection of viral technologies into mice or rats
  • Human brain organogenesis
  • RNAscope

Eligibility

  • The proposal must be related to understanding the brain function in health and disease and relevant to the aims of the NIH Brain Initiative.
  • Basic science or translational Neuroscience are both welcomed.
  • Proposals must be submitted by either the principal investigator or a lead researcher/scientist in the research program. 

Selection Criteria

Proposals will be evaluated regarding their scientific merit and feasibility by an appointed review committee. 

Application Submission

Download RFA for Application Details. Proposals should be submitted as a PDF file or Microsoft Word document to sprintneuro@stanford.edu with the file name and subject line as, Last Name of Applicant SPrINT Pilot Project. Successful submission will be confirmed by email notification.